Bruker Introduces First of Its Kind Dimensional Analysis System

STUTTGART, Germany - At the 30th Control International trade fair for quality assurance, Bruker (NASDAQ: BRKR) announced the release of the innovative and unique Contour CMM™ dimensional analysis system, which is the world’s first non-contact metrology system to perform simultaneous nanoscale surface height, texture, waviness and form measurements, as well as 3D coordinate measurements for [...]

Takara Bio USA, Inc. and Integrated DNA Technologies Announce Collaboration to Support Targeted RNA Sequencing

Mountain View, CA, and Coralville, IA — Takara Bio USA, Inc. (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., and Integrated DNA Technologies (IDT) announced a new collaboration to support targeted RNA sequencing. This relationship will leverage IDT’s unrivalled proficiency in the manufacture and quality control of long oligonucleotides and [...]

SPECTRO Analytical Instruments and BALVER ZINN Join Forces on Tin Solder Bath Analysis Application

Kleve/Balve, Germany, – Two highly respected industry leaders, SPECTRO Analytical Instruments GmbH and BALVER ZINN Josef Jost GmbH & Co. KG, have joined forces in developing a joint application for tin solder bath analysis that they are presenting at the SMT Hybrid Packaging Trade Fair at the Nuremberg Exhibition Centre, April 26 to 28, 2016. [...]

Human Longevity, Inc. Announces 10 Year Deal with AstraZeneca to Sequence and Analyze Patient Samples from AstraZeneca Clinical Trials

SAN DIEGO, CA — Human Longevity, Inc. (HLI), the genomics-based, technology-driven company working to revolutionize the practice of medicine, announced today a 10 year deal with AstraZeneca to sequence and analyze up to 500,000 DNA samples from AstraZeneca clinical trials. The genomic insights from the collaboration will be added to the HLI Knowledgebase™, building upon [...]

The Binding Site & Rockland Immunochemicals Enter into Distribution Agreement

UK based specialist diagnostic manufacturer, The Binding Site Group Ltd, is pleased to announce that it has entered into an exclusive, definitive agreement with Rockland Immunochemicals, Inc., of Limerick, PA, to grant Rockland global distribution rights for Binding Site’s line of animal-focused radial immunodiffusion (RID) test kits. The availability of this unique range of products [...]

Innova Biosciences Expands UK Facility & Increases Laboratory Space

Cambridge, UK - Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, announced it has expanded its UK footprint to enable the company to increase its laboratory space. Innova’s sales and marketing teams have moved from the Babraham Research Park to Ashwell Point in Sawston, accommodating another 2500 sq ft of office space [...]

FEI and CEOS deliver First Sub-Angstrom, Low-Voltage Electron (SALVE) Microscope to the University of Ulm

Hillsboro, Ore. and Heidelberg, Germany - FEI (NASDAQ: FEIC) and CEOS announced that they have delivered the first sub-Ångstrom, low-voltage electron (SALVE) microscope to the University of Ulm. The microscope, equipped with a Cc/Cs-corrector from CEOS, was developed in collaboration with the University of Ulm. It uses electrons with energies between 20keV and 80keV, much [...]

Safran enters into an agreement for the sale of Morpho Detection

Paris, April 21, 2016 - Safran (Euronext Paris: SAF) announced that it has reached an agreement to sell Morpho Detection LLC, a US-based subsidiary of Safran, and other detection related activities to Smiths Group plc for an enterprise value of $710 million. Headquartered in Newark, California, Morpho Detection provides solutions for detecting and identifying chemical, [...]

High-throughput 96-Well Array for Direct Measurement of DNA Damage

AMSBIO has announced the launch of the 96-Well CometChip® System - a high-throughput platform developed to simultaneously treat and measure DNA damage induced by different treatments, or among different cell types on a single slide using the Comet assay. DNA damaging agents can promote aging, disease and cancer and are widespread in the environment as [...]

PerkinElmer Board Declares Quarterly Dividend

WALTHAM, Mass. - The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on April 25, 2016. This dividend is payable on August 10, 2016 to all shareholders of record at the close of business on July 15, 2016. About PerkinElmer PerkinElmer, Inc. is [...]

Access IBO on Knowledge Center